Victory Capital Management Inc Cytokinetics Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 35,604 shares of CYTK stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,604

Previous 37,039 3.87%

Holding current value

$1.7 Million

Previous $2.01 Million 6.33%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$51.22 - $60.16 $73,500 - $86,329	-1,435 Reduced 3.87%	35,604 $1.88 Million
Q2 2024 Aug 05, 2024	BUY	$47.86 - $75.05 $164,446 - $257,871	3,436 Added 10.23%	37,039 $2.01 Million
Q1 2024 May 03, 2024	SELL	$63.75 - $108.06 $10.1 Million - $17.1 Million	-158,051 Reduced 82.47%	33,603 $2.36 Million
Q4 2023 Feb 05, 2024	BUY	$26.88 - $83.49 $4.7 Million - $14.6 Million	174,848 Added 1040.39%	191,654 $16 Million
Q3 2023 Nov 06, 2023	BUY	$29.46 - $36.61 $32,140 - $39,941	1,091 Added 6.94%	16,806 $495,000
Q2 2023 Jul 27, 2023	BUY	$32.62 - $40.75 $10,438 - $13,040	320 Added 2.08%	15,715 $512,000
Q1 2023 May 02, 2023	SELL	$33.36 - $45.71 $2.34 Million - $3.2 Million	-70,037 Reduced 81.98%	15,395 $541,000
Q4 2022 Feb 10, 2023	BUY	$35.77 - $51.11 $572,892 - $818,577	16,016 Added 23.07%	85,432 $3.91 Million
Q4 2022 Feb 09, 2023	SELL	$35.77 - $51.11 $19 Million - $27.1 Million	-529,812 Reduced 88.42%	69,416 $3.18 Million
Q3 2022 Nov 02, 2022	BUY	$38.54 - $54.52 $20.2 Million - $28.5 Million	523,279 Added 688.99%	599,228 $29 Million
Q2 2022 Aug 01, 2022	BUY	$33.93 - $48.92 $1.79 Million - $2.59 Million	52,886 Added 229.31%	75,949 $2.98 Million
Q1 2022 May 04, 2022	BUY	$29.74 - $46.0 $428,196 - $662,308	14,398 Added 166.16%	23,063 $920,000
Q4 2021 Feb 07, 2022	SELL	$34.35 - $46.38 $37,991 - $51,296	-1,106 Reduced 11.32%	8,665 $395,000
Q3 2021 Nov 02, 2021	BUY	$18.54 - $35.74 $181,154 - $349,215	9,771 New	9,771 $349,000
Q2 2021 Aug 03, 2021	SELL	$19.79 - $26.99 $196,574 - $268,091	-9,933 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$18.57 - $25.68 $184,455 - $255,079	9,933 New	9,933 $231,000
Q2 2020 Aug 07, 2020	SELL	$11.15 - $24.64 $90,147 - $199,214	-8,085 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$8.75 - $16.3 $28,752 - $53,561	-3,286 Reduced 28.9%	8,085 $95,000
Q4 2019 Feb 06, 2020	BUY	$7.95 - $11.84 $24,652 - $36,715	3,101 Added 37.5%	11,371 $121,000
Q4 2019 Feb 04, 2020	SELL	$7.95 - $11.84 $349 - $520	-44 Reduced 0.53%	8,270 $102,000
Q3 2019 Nov 12, 2019	BUY	$10.82 - $14.25 $89,957 - $118,474	8,314 New	8,314 $95,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.49B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Cytokinetics Inc Transaction History